All Stories

  1. Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model
  2. Modulatory role of shear stress in cerebral cavernous malformation
  3. Knockin expression of human ADAMTS5 impairs cardiovascular development and aggravates cerebral cavernous malformations in mice
  4. Liver Endothelial Heg1 Signal Limits Hepatic Steatosis via Wnt-Mediated Fatty Acid Oxidation in Hepatocytes
  5. Hmx2 and Dmrt2 Coordinate the Differentiation of Intercalated Cell Subtypes in Kidney
  6. Shear stress-induced endothelial HEG1 signalling regulates vascular tone and blood pressure
  7. Deubiquitinase USP9X controls Wnt signaling for CNS vascular formation and barrier maintenance
  8. Proteins regulate the production of acid-base balance controlling cells in kidney
  9. Deficiency of Pdcd10 causes urothelium hypertrophy and vesicle trafficking defects in ureter
  10. Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targets
  11. Multi-omics profiling of cholangiocytes reveals sex-specific chromatin state dynamics during hepatic cystogenesis in polycystic liver disease
  12. Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation
  13. Role of pericytes in the development of cerebral cavernous malformations
  14. Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells
  15. KANK4 Promotes Arteriogenesis by Potentiating VEGFR2 Signaling in a TALIN-1–Dependent Manner
  16. Liver Endothelial Heg Regulates Vascular/Biliary Network Patterning and Metabolic Zonation Via Wnt Signaling
  17. Pdcd10-Stk24/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting
  18. Cell Cycle Withdrawal Limit the Regenerative Potential of Neonatal Cardiomyocytes
  19. CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway
  20. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
  21. Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice
  22. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy
  23. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
  24. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways
  25. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation
  26. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway
  27. Cell-Specific Effects of GATA (GATA Zinc Finger Transcription Factor Family)-6 in Vascular Smooth Muscle and Endothelial Cells on Vascular Injury Neointimal Formation
  28. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations
  29. Elevated Expression of miR302-367 in Endothelial Cells Inhibits Developmental Angiogenesis via CDC42/CCND1 Mediated Signaling Pathways
  30. Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
  31. Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
  32. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations
  33. A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability
  34. Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice
  35. Cerebral cavernous malformations arise from endothelial gain of MEKK3–KLF2/4 signalling
  36. The Cerebral Cavernous Malformation Pathway Controls Cardiac Development via Regulation of Endocardial MEKK3 Signaling and KLF Expression
  37. Cerebral Cavernous Malformations Arise Independent of the Heart of Glass Receptor
  38. Dynamic Regulation of the Cerebral Cavernous Malformation Pathway Controls Vascular Stability and Growth
  39. Aquaporin-3 in keratinocytes and skin: Its role and interaction with phospholipase D2
  40. CCM3 signaling through sterile 20–like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations
  41. Erratum: Corrigendum: Regulation of cardiovascular development and integrity by the heart of glass– cerebral cavernous malformation protein pathway
  42. Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish
  43. Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathway
  44. A Potential Role for the Phospholipase D2-Aquaporin-3 Signaling Module in Early Keratinocyte Differentiation: Production of a Phosphatidylglycerol Signaling Lipid
  45. Enrichment of regulatory CD4+CD25+ T cells by inhibition of phospholipase D signaling
  46. Phospholipase D Signaling and Extracellular Signal-Regulated Kinase-1 and -2 Phosphorylation (Activation) Are Required for Maximal Phorbol Ester-Induced Transglutaminase Activity, a Marker of Keratinocyte Differentiation
  47. Aquaporin 3 Colocates with Phospholipase D2 in Caveolin-Rich Membrane Microdomains and Is Downregulated Upon Keratinocyte Differentiation
  48. Modulation of phospholipase D-mediated phosphatidylglycerol formation by differentiating agents in primary mouse epidermal keratinocytes
  49. AngII induces transient phospholipase D activity in the H295R glomerulosa cell model
  50. Elevated K+ induces myristoylated alanine-rich C-kinase substrate phosphorylation and phospholipase D activation in glomerulosa cells
  51. Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family